Nicolas Bamat, MD, MSCE
Locations: Main Building, CHOP at Penn Medicine Hospital of the University of Pennsylvania
About Nicolas Bamat, MD, MSCE
Nicolas Bamat, MD, MSCE, is an attending neonatologist in the Division of Neonatology at Children's Hospital of Philadelphia. His clinical work is centered on the Newborn & Infant Chronic Lung Disease Program. Dr. Bamat's research program is focused on identifying safe and effective pharmacotherapies for preterm lung disease through clinical pharmacology, pharmacoepidemiology and clinical trials.
Titles
Attending Neonatologist
Assistant Professor, Perelman School of Medicine at the University of Pennsylvania
Certifications
Pediatrics – American Board of Pediatrics
Awards and Honors
2019, Early Career Faculty Honor Roll, The Children’s Hospital of Philadelphia
2015, Outstanding Teaching Award by a Fellow in Neonatology (awarded by division)
2014, Outstanding Teaching Award by a Fellow in Neonatology (awarded by division)
2014, William Pottash Fellow Teacher of the Year Award (awarded by residency program)
Leadership and Memberships
Memberships in Professional Organizations
2020-present, Operations Lead and Executive Board Member, The International Society for Evidence Based Neonatology (EBNEO)
2013- present, American Board of Pediatrics
2013- present, Society for Pediatric Research
Editorial and Academic Positions
2020-present, Associate Editor, Cochrane Neonatal
Education & training
Graduate Degree
MSCE - University of Pennsylvania School of Medicine, Philadelphia, PA
Medical Degree
MD – University of Pennsylvania School of Medicine, Philadelphia, PA
Residency
Pediatrics – The Children’s Hospital of Philadelphia, Philadelphia, PA
Fellowship
Neonatology - The Children's Hospital of Philadelphia, Philadelphia, PA
Publications
Publications
2022
Nic Bamat, Scott Lorch, Eric Eichenwald Association between postmenstrual age and furosemide dosing practices in very preterm infants. Bamat NA, Thompson EJ, Greenberg RG, Lorch SA, Zuppa AF, Eichenwald EC, Tolia VN, Clark RH, Smith PB, Hornik CP, Lang JE, Laughon MM. J Perinatol. 2022 Jan 24. doi: 10.1038/s41372-022-01320-w. Online ahead of print. PMID: 35075306.
Bamat NA, Thompson EJ, Greenberg RG, Lorch SA, Zuppa AF, Eichenwald EC, Tolia VN, Clark RH, Smith PB, Hornik CP, Lang JE, Laughon MM. Association between postmenstrual age and furosemide dosing practices in very preterm infants. [Published online ahead of print Jan. 24, 2022] J Perinatol.
Proaño A, Keir A, Campbell DM, Courchia B, Narvey M, Bamat NA. #neoTwitter: evaluation of its use within the neonatal-perinatal community. J Perinatol.2022 Oct;42(10):1409-1411. doi: 10.1038/s41372-022-01373-x. Epub 2022 Mar 31. PubMed PMID: 35361886; PubMed Central PMCID: PMC9522885.
Bamat NA, Vereen RJ, Montoya-Williams D. Disparities in Lung Disease of Prematurity-When Does Exposure to Racism Begin?. JAMA Pediatr. 2022 Sep 1;176(9):845-847. doi: 10.1001/jamapediatrics.2022.2671. PubMed PMID: 35913709.
Bamat NA, Orians CM, Abbasi S, Morley CJ, Ross Russell R, Panitch HB, Handley SC, Foglia EE, Posencheg MA, Kirpalani H. Use of ventilation/perfusion mismatch to guide individualised CPAP level selection in preterm infants: a feasibility trial. Arch Dis Child Fetal Neonatal Ed. 2022 Sep 14;. doi: 10.1136/archdischild-2022-324474. [Epub ahead of print] PubMed PMID: 36104165.
Bamat NA, Vedar C, Reilly ME, Moorthy GS, Zuppa AF. A whole blood microsampling furosemide assay: development, validation and use in a pediatric pharmacokinetic study. Bioanalysis. 2022 Aug;14(15):1025-1038. doi: 10.4155/bio-2022-0063. Epub 2022 Sep 27. PubMed PMID: 36165919; PubMed Central PMCID: PMC9540403.
Vyas-Read S, Jensen EA, Bamat N, Lagatta JM, Murthy K, Patel RM. Chronic lung disease-related mortality in the US from 1999-2017: trends and racial disparities. J Perinatol. 2022 Sep;42(9):1244-1245. doi: 10.1038/s41372-022-01468-5. Epub 2022 Jul 29. PubMed PMID: 35906284.
Nitkin CR, Bamat NA, Lagatta J, DeMauro SB, Lee HC, Patel RM, King B, Slaughter JL, Campbell JP, Richardson T, Lewis T. Pulmonary Hypertension in Preterm Infants Treated With Laser vs Anti-Vascular Endothelial Growth Factor Therapy for Retinopathy of Prematurity. JAMA Ophthalmol. 2022 Nov 1;140(11):1085-1094. doi: 10.1001/jamaophthalmol.2022.3788. PubMed PMID: 36201183; PubMed Central PMCID: PMC9539731.
DeMauro SB, Burkhardt M, Wood A, Nilan K, Jensen EA, Bamat NA, Zhang H, Gibbs K. Early motor development in infants with moderate or severe bronchopulmonary dysplasia. J Neonatal Perinatal Med. 2022;15(1):55-62.